221 related articles for article (PubMed ID: 19336266)
1. Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing.
Meijer K; Kim YK; Schulman S
Thromb Res; 2010 Mar; 125(3):224-9. PubMed ID: 19336266
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
Meijer K; Kim YK; Carter D; Schulman S
Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
[TBL] [Abstract][Full Text] [Related]
3. Warfarin sensitivity after mechanical heart valve replacement.
Rose JP; Rihn TL; Long SF
Pharmacotherapy; 1998; 18(4):856-9. PubMed ID: 9692661
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity to warfarin after heart valve replacement.
Rahman M; BinEsmael TM; Payne N; Butchart EG
Ann Pharmacother; 2006 Mar; 40(3):397-401. PubMed ID: 16507614
[TBL] [Abstract][Full Text] [Related]
5. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
Schultz KT; Bungard TJ
Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
[TBL] [Abstract][Full Text] [Related]
6. Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice.
Onundarson PT; Einarsdottir KA; Gudmundsdottir BR
Int J Lab Hematol; 2008 Oct; 30(5):382-9. PubMed ID: 19046313
[TBL] [Abstract][Full Text] [Related]
7. Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.
Schulman S; Melinyshyn A; Ennis D; Rudd-Scott L
Thromb Res; 2010 May; 125(5):393-7. PubMed ID: 19640572
[TBL] [Abstract][Full Text] [Related]
8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
[TBL] [Abstract][Full Text] [Related]
10. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
[TBL] [Abstract][Full Text] [Related]
11. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ
J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309
[TBL] [Abstract][Full Text] [Related]
12. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
[TBL] [Abstract][Full Text] [Related]
13. Comparison of physician- and pharmacist-managed warfarin sodium treatment in open heart surgery patients.
Tschol N; Lai DK; Tilley JA; Wong H; Brown GR
Can J Cardiol; 2003 Nov; 19(12):1413-7. PubMed ID: 14631476
[TBL] [Abstract][Full Text] [Related]
14. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
[TBL] [Abstract][Full Text] [Related]
15. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of subtherapeutic anticoagulation in the United States.
Rose AJ; Ozonoff A; Grant RW; Henault LE; Hylek EM
Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):591-7. PubMed ID: 20031897
[TBL] [Abstract][Full Text] [Related]
17. Clinical factors influencing the sensitivity to warfarin when restarted after surgery.
Schulman S; El Bouazzaoui B; Eikelboom JW; Zondag M
J Intern Med; 2008 Apr; 263(4):412-9. PubMed ID: 18205763
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.
Wong CS; Batchelor K; Bua J; Newall F
Thromb Res; 2011 Oct; 128(4):331-4. PubMed ID: 21620442
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
20. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.
Nochowitz B; Shapiro NL; Nutescu EA; Cavallari LH
Ann Pharmacother; 2009 Jul; 43(7):1165-72. PubMed ID: 19549747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
